1. Home
  2. THFF vs ACHV Comparison

THFF vs ACHV Comparison

Compare THFF & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Financial Corporation Indiana

THFF

First Financial Corporation Indiana

N/A

Current Price

$76.07

Market Cap

881.8M

Sector

Finance

ML Signal

N/A

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

N/A

Current Price

$6.73

Market Cap

726.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
THFF
ACHV
Founded
1984
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
881.8M
726.5M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
THFF
ACHV
Price
$76.07
$6.73
Analyst Decision
Hold
Strong Buy
Analyst Count
4
12
Target Price
★ $85.33
$14.15
AVG Volume (30 Days)
132.0K
★ 1.3M
Earning Date
10-27-2026
11-17-2026
Dividend Yield
★ 2.92%
N/A
EPS Growth
★ 67.00
N/A
EPS
★ 5.89
N/A
Revenue
N/A
N/A
Revenue This Year
$10.67
N/A
Revenue Next Year
$16.17
N/A
P/E Ratio
$13.45
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$54.76
$2.62
52 Week High
$84.17
$8.64

Technical Indicators

Market Signals
Indicator
THFF
ACHV
Relative Strength Index (RSI) 50.47 45.05
Support Level $74.32 $5.96
Resistance Level $78.70 $6.64
Average True Range (ATR) 1.96 0.41
MACD 0.18 0.02
Stochastic Oscillator 33.52 35.10

Price Performance

Historical Comparison
THFF
ACHV

About THFF First Financial Corporation Indiana

First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities. Company's loan portfolio was diversified in Commercial, Residential and consumer domains.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: